Correction for Slevin and Payne, BMJ 329 (7458) 124-126.

BMJ  2004;329:499 (28 August), doi:10.1136/bmj.329.7464.499

Correction

New treatments for colon cancer

Some errors occurred in this editorial by Maurice Slevin and Sarah Payne (17 July, pp 124-6). The misspelling of a drug persisted to publication—cetuximab was spelt wrongly throughout the article. The drug's manufacturer, Merck, has pointed out that the drug is licensed in many countries, not just Switzerland and the United States, as the article implied, and marketing authorisation was granted in the European Union at the end of June 2004.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Access jobs at BMJ Careers
Whats new online at Student BMJ